RA Medical Systems (NYSE:RMED) issued its quarterly earnings results on Friday. The company reported ($1.30) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.50) by ($0.80), MarketWatch Earnings reports.
RMED stock opened at $1.27 on Friday. RA Medical Systems has a 1-year low of $1.06 and a 1-year high of $10.43. The firm has a market cap of $18.75 million, a P/E ratio of -0.38 and a beta of 2.14. The business’s 50 day moving average is $1.45 and its 200-day moving average is $2.36. The company has a current ratio of 11.89, a quick ratio of 11.45 and a debt-to-equity ratio of 0.06.
Several equities research analysts have recently weighed in on RMED shares. Cantor Fitzgerald lowered RA Medical Systems from an “overweight” rating to a “neutral” rating and lowered their price objective for the company from $10.00 to $2.00 in a research note on Tuesday, August 13th. Piper Jaffray Companies lowered RA Medical Systems from an “overweight” rating to a “neutral” rating and lowered their price objective for the company from $9.00 to $1.50 in a research note on Tuesday, August 13th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $6.38.
About RA Medical Systems
Ra Medical Systems, Inc, a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease.
Featured Story: What does RSI mean?
Receive News & Ratings for RA Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RA Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.